// App-Quantinova.ai

: A genome-wide association study of asthma-COPD overlap syndrome (ACOS

Researchers

Presenter

  • Catherine John

Principal Investigators

  • Nick Shrine

  • Thorunn Olafsdottir

  • Jiangyuan Liu

  • Lystra Hayden

  • Su H Chu

  • Jukka Koskela

  • Jian'An Luan

  • Xingnan Li

  • Natalie Terzikhan

  • Hanfei Xu

  • Traci M Bartz

  • Hans Petersen

  • Shuguang Leng

  • Gudmar Thorleifsson

  • Deborah A Meyers

  • Eugene R Bleecker

  • Lori C Sakoda

  • Carlos Iribarren

  • Yohannes Tesfaigzi

  • Sina A Gharib

  • Josee Dupuis

  • Lies Lahousse

  • Victor E Ortega

  • Kari Stefansson

  • Ian Sayers

  • Ian P Hall

  • Claudia Langenberg

  • Samuli Ripatti

  • Tarja Laitinen

  • Ann C Wu

  • Jessica Lasky-Su

  • Caroline Hayward

  • Ben Brumpton

  • Arnulf Langhammer

  • Ingileif Jonsdottir

  • Michael H Cho

  • Louise V Wain

  • Martin D Tobin

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • deCODE genetics/Amgen and University of Iceland, Reyjavik, Iceland

  • Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, United States of America

  • Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.

  • MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom

  • University of Arizona, Tucson, AZ, United States of America

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • Boston University School of Public Health, Boston, United States of America

  • University of Washington, Washington, United States of America

  • Lovelace Respiratory Research Institute, Albuquerque, United States of America

  • deCODE genetics/Amgen and University of Iceland, Reyjavik, Iceland

  • Division of Research, Kaiser Permanente of Northern California, Oakland, United States of America

  • Wake Forrest School of Medicine, Winston-Salem, United States of America

  • University of Nottingham, NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom

  • Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland

  • Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, United States of America

  • Gastrointestinal Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom

  • Norwegian University of Science and Technology (NTNU, Levanger, Norway

  • University of Leeds and LTHT NIHR Biomedical Research Centre, Leeds, United Kingdom

Locations

  • United Kingdom

  • Iceland

  • United States

  • Finland

  • Netherlands

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

Disease

  • Autoimmune sclerosing cholangitis

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • Prohibitin

  • Major Histocompatibility Complex, Class II, DQ Beta 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved